Metals/mining stocks trading higher: NEM +1.1%, SLV +0.9%, GG +0.7%, GDX +0.4%, GLD +0.1%.
A few Brazil related names are seeing modest strength: VALE +1.5% BBD +1.4%, ABEV +0.6%, PBR +1.2% (will release its Q3 2014 financial statements in January 2015 without the PricewaterhouseCoopers external auditors' report, reiterates that it is reviewing its planning for the year 2015).
Other news: OGXI +19.8% (announces that it has executed an initial agreement with Teva to regain rights to custirsen; will receive a $27 million payment from Teva), XNPT +13% (positive analyst comments on CNBC), NDRM +9.1% (announces topline results of Phase IIa Pharmacokinetic Study of ND0612H and ND0612L; results suggest may provide an effective therapy alternative to current treatments requiring surgery), CJJD +7.3% (after 26% move higher yesterday), RPRX +6.2% (updates Androxal global regulatory status; initiates two Phase 2B Uterine Fibroid Studies), ARCP +4.4% (Corvex discloses 7.1% stake in 13D - had discussions to explore additions to the Board; American Realty Capital says 'he Board will continue to prioritize transparency and an open dialogue with all stockholders'), FMD +3.7% (HC2 Investment Securities discloses 8.56% active stake in 13D filing), TKMR +2.5% (light volume; ongoing volatility in select ebola related names), IDRA +2.2% (provides updates on clinical development of IMO-8400 for Treatment of Waldenstrom's Macroglobulinemia; confirms FDA grants Orphan Drug Designation for IMO-8400), PTRY +1.1% (Gabelli discloses 5.24% active stake in 13D filing ), BBY +1.1% (Jon Najarian said he was a buyer), GRPN +0.8% (Goldman Sachs may soon invest in GRPN unit, according to NYPost ), CKH +0.7% (announces $150 mln increase in share repurchase authorization), KLIC +0.4% (acquires 100% equity stake of Assembléon B.V., in an all cash transaction for $98 mln), OAS +0.4% (ticking higher; SPO Partners discloses 7.1% stake; has had discussions with mgmt and intends to continue to discuss matters, including strategic alternatives).
Analyst comments: CNV +3% (ticking higher, initiated by several analysts)